Role of Topical Vancomycin in Reducing Infections in Hip and Knee Arthroplasty
- Conditions
- Osteoarthritis, KneeOsteoarthritis, HipAvascular Necrosis of HipRheumatoid Arthritis
- Interventions
- Procedure: 0,35% povidone-iodine solution lavageProcedure: 1.0 g Vancomycin powder into the wound
- Registration Number
- NCT05972603
- Lead Sponsor
- Independent Public Healthcare Center in Rypin
- Brief Summary
The study is designed to assess the efficacy of vancomycin powder and dilute povidone-iodine lavage (VIP protocol) in reducing the PJI after primary Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA). We hypothesized that VIP protocol provides superior reduction of periprosthetic joint infection (PJI) rates after primary THA and TKA compared with diluted povidone-iodine (PI) protocol.
- Detailed Description
Patients who undergo primary hip or knee arthroplasty, before closure 0,35% povidone-iodine (17,5mL in 500 mL saline) solution lavage left for 3 minutes following final implantation.
Patients drawn by random numbers calculator will be administered with 1.0 g Vancomycin powder into the wound around the prosthesis and no suction will be used.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- undergoing THA or TKA as a result of osteoarthritis or rheumatoid arthritis, can understand and comply with the study protocol, have signed the informed consent document at screening
- Patients referred to the hospital in order to undergo THA or TKA due to different reason than osteoarthritis, rheumatoid arthritis or avascular necrosis of the femoral head, such as: failed femoral neck fractures, displaced acetabular fractures or revision acetabular fractures, revision knee or hip arthroplasty
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 0,35% povidone-iodine solution lavage 0,35% povidone-iodine solution lavage 0,35% povidone-iodine solution lavage left in wound for 3 minutes following final implantation. 1.0 g Vancomycin powder into the wound 1.0 g Vancomycin powder into the wound additional 1.0 g Vancomycin powder into the wound
- Primary Outcome Measures
Name Time Method periprosthetic joint infection 90 days infection rate in each group
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
IPHC Rypin
🇵🇱Rypin, Kujawsko-pomorksie, Poland